Anti-Human IGF1 Receptor Therapeutic Antibody (Figitumumab)
Recombinant monoclonal antibody to IGF1 Receptor. Figitumumab (previously CP-751871) is a monoclonal antibody targeting the insulin-like growth factor-1 receptor being investigated for the treatment of various types of cancer, for example adrenocortical carcinoma and non-small cell lung cancer (NSCLC).
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-232 |
| Pricing | Inquiry |
| Host | Human |
| Target | IGF1 Receptor |
| Species Reactivity | Human |
| Type | IgG2 - kappa |
| Applications | WB, IF, IP, Neut, FuncS, ELISA, FC, Block, Inhib |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |